NRAS(Q61R), BRAF(V600E) immunohistochemistry: a concomitant tool for mutation screening in melanomas

BACKGROUND: The determination of NRAS and BRAF mutation status is a major requirement in the treatment of patients with metastatic melanoma. Mutation specific antibodies against NRAS(Q61R) and BRAF(V600E) proteins could offer additional data on tumor heterogeneity. The specificity and sensitivity of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diagn Pathol
Main Authors: Uguen, Arnaud, Talagas, Matthieu, Costa, Sebastian, Samaison, Laura, Paule, Laure, Alavi, Zarrin, De Braekeleer, Marc, Le Marechal, Cédric, Marcorelles, Pascale
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4513673/
https://ncbi.nlm.nih.gov/pubmed/26204954
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13000-015-0359-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados